Remove 2010 Remove Advocacy Remove Clinical Trials Remove Collective
article thumbnail

New Study: Demographic and policy-based differences in behaviors and attitudes towards driving after marijuana use: an analysis of the 2013–2017 Traffic Safety Culture Index

Cannabis Law Report

An alternative approach to study relationships between marijuana policies and driving after marijuana use is to use surveys that collect information on self-reported behaviors and attitudes. Marijuana Decriminalization, Medical Marijuana Laws, and Fatal Traffic Crashes in US Cities, 2010–2017. Accident Anal Prev. 2019;132:105284.

Policy 59
article thumbnail

A Hidden Origin Story of the CBD Craze

SMPL

Mr. Gardner, the writer whose CBD advocacy eventually inspired the 2011 summit at Ms. In June of 2010, the host of the 2011 summit, the biochemist Ms. In the fall of 2010, a Project CBD website was set up where anyone could look through studies organized by disease or condition. has yet to approve Sativex in the United States.

CBD 40
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Paper: The transition of cannabis into the mainstream of Australian healthcare: framings in professional medical publications

Cannabis Law Report

Data collection. However, from 2010, a dramatic increase is observable in articles about medicinal cannabis in the publications under analysis. The number of articles across the longitudinal period can be viewed in Fig. Only one article appeared in the MJA in 2000 and again in 2001. Complexity of prescribing and patient access (n?=?25).

article thumbnail

Psychedelic Invest’s 100 Most Influential People in Psychedelics List

Cannabis Law Report

Rick, and MAPS, have published hundreds of research papers, articles, and reports over the past several decades in addition to participation in dozens of clinical trials and international studies. He is the chairman of Drug Science, a non-profit which he founded in 2010 to provide independent, evidence-based information on drugs.